Comera Life Sciences Holdings Inc (CMRA) Peer Comparison

$0.02

$-0.01 (-23.45%)

As on 03-Oct-2024 16:00EDT

Market cap

$1 Mln

Revenue (TTM)

$1 Mln

P/E Ratio

--

P/B Ratio

0

Div. Yield

0 %

Edit

	Comera Life Sciences Holdings Inc (CMRA)	Reneo Pharmaceuticals (RPHM)
Market cap ($ Mln)	1	61
Revenue ($ Mln)	1	1
Net Profit ($ Mln)	-84.25	-56.54
Net Margin (%)	-8,421.91	-3,851.29
RoE (%)	--	-68.33
Price to Earnings	--	--
Price-To-Book	--	0.79

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Comera Life Sciences Holdings Inc (CMRA)	Reneo Pharmaceuticals (RPHM)
Operating Revenue	1.00	0.00
Cost of Revenue	0.26	0.53
Gross Profit	0.42	-0.53
Operating Expenses	9.88	53.85
Operating Profit (EBIT)	-9.15	-53.85
Other Income	0.00	1.89
Profit before Tax	-9.01	-51.96
Provision for Tax	75.23	-1.89
Profit after Tax (Net Income)	-84.25	-50.06
Minority Interest	0.00	--
Consolidated Profit	-6.04	-51.96

Liabilities ($ Mln)

	Comera Life Sciences Holdings Inc (CMRA)	Reneo Pharmaceuticals (RPHM)
Shareholder's Funds	-4.22	99.97
Minority Interest	0.00	--
Non-Current Liabilities	4.36	1.09
Current Liabilities	2.93	7.12
Total Liabilities	3.73	108.18

Assets ($ Mln)

	Comera Life Sciences Holdings Inc (CMRA)	Reneo Pharmaceuticals (RPHM)
Non-Current Assets	0.44	1.83
Current Assets	2.63	106.35
Total Assets	3.73	108.18
Total Debt*	0.17	1.46
Net Current Assets	-0.30	99.23

Cashflow ($ Mln)

	Comera Life Sciences Holdings Inc (CMRA)	Reneo Pharmaceuticals (RPHM)
Cash From Operating Activities	-9.77	-47.36
Cash Flow from Investing Activities	-0.03	-57.84
Cash from Financing Activities	5.24	0.47
Net Cash Inflow / Outflow	--	-104.73

Ratios

Profitability Ratios

	Comera Life Sciences Holdings Inc (CMRA)	Reneo Pharmaceuticals (RPHM)
ROCE (%)	242.38	-40.27
ROE (%)	229.66	-40.51
ROA (%)	-1,172.49	-38.19
EBIT Margin (%)	-917.18	--
Net Margin (%)	-8,421.91	-2,644.59
Cash Profit Margin (%)	-0.08	--

Growth Ratios

	Comera Life Sciences Holdings Inc (CMRA)	Reneo Pharmaceuticals (RPHM)
Revenue Growth (%)	81.79	--
EBIT Growth (%)	17.27	--
Net Profit Growth (%)	-264.00	-25.88
EPS Growth (%)	-101.53	--
Book Value Growth (%)	14.64	--

Valuation Ratios

	Comera Life Sciences Holdings Inc (CMRA)	Reneo Pharmaceuticals (RPHM)
Price / Earnings	-0.53	--
Price / Book Value	-2.06	--
Dividend Yield (%)	--	--
EV/EBITDA	-0.99	1.85
Market Cap ($ Cr)	--	--

Solvency Ratios

	Comera Life Sciences Holdings Inc (CMRA)	Reneo Pharmaceuticals (RPHM)
Debt to Equity	0.00	0.01
Short term debt to equity ratio	-0.04	0.00
Current Ratio	0.90	14.93
Quick Ratio	0.93	--
Interest Coverage	-356.82	-28.68

Operating Efficiency Ratios

	Comera Life Sciences Holdings Inc (CMRA)	Reneo Pharmaceuticals (RPHM)
Debtors to sales (%)	10.00	--
Asset Turnover	0.14	0.00
Receivable days	73.81	--
Inventory Days	2,179.87	--
Payable days	1,627.74	1,351.56
Cash Conversion Cycle	625.94	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly